This analysis revealed striking differences in how the metabolism of a leukemic cell differs from that of a T cell and identified specific potential targets for cancer therapy, including Hmgcs2, Prodh, Ldhb, Fbp1, and Chdh. This evidence concerns the gene LDHB and cancer.